Our results clearly indicate that bFGF and selenium can enhance in vitro expansion of AF-MSCs by activating the AKT-ERK1/2, Smad2, and Stat3 signaling pathways, inactivating GSK3β and inhibiting ROS accumulation (Fig. 2). Here, FGF2 is linked to atrial fibrillation.